Brilakis Emmanouil S, Karmpaliotis Dimitri, Patel Vishal, Banerjee Subhash
Division of Cardiology, VA North Texas Health Care System, The University of Texas Southwestern Medical Center at Dallas, 4500 South Lancaster Road, Dallas, TX 75216, USA.
Piedmont Heart Institute, 275 Collier Road North West, Suite 300, Atlanta, GA 30309, USA.
Interv Cardiol Clin. 2012 Jul;1(3):373-389. doi: 10.1016/j.iccl.2012.04.006. Epub 2012 May 31.
Every percutaneous coronary intervention carries risk for acute and long-term complications. This is also true of chronic total occlusion (CTO) interventions, which can also have complications specific to specialized techniques, such as retrograde crossing and dissection/reentry techniques. Acute CTO intervention complications can be coronary artery-related, cardiac noncoronary, or noncardiac. In the long term, CTO interventions can be complicated by in-stent restenosis, stent thrombosis, or coronary aneurysm formation. Understanding of the pathogenesis of possible CTO intervention complications can facilitate prevention, early recognition, and prompt treatment.
每一次经皮冠状动脉介入治疗都有发生急性和长期并发症的风险。慢性完全闭塞(CTO)介入治疗亦是如此,其也可能出现特定于专业技术(如逆向通过和夹层/再入技术)的并发症。急性CTO介入治疗并发症可能与冠状动脉相关、心脏非冠状动脉性或非心脏性并发症有关。从长期来看,CTO介入治疗可能会并发支架内再狭窄、支架血栓形成或冠状动脉瘤形成。了解CTO介入治疗可能并发症的发病机制有助于预防、早期识别和及时治疗。